Investor Temperature Check: What’s Hot and What’s Not for EU and US investors
Wednesday, September 4, 2024 08:00 AM - 09:00 AM
F3
Roundtable Session
Moderator:
Session Objectives:
- Sven Kili, MBChB, MRCS (Eng), CCRM, Sven Kili Consulting, Saisei Ventures, United Kingdom
- Philip Vanek, PhD, Gamma Biosciences, United States
- Ingrid Gafanhão, MSc, Redwheel, United Kingdom
The roundtable aims to discuss what is the investor perspective when looking at opportunities in CGT, highlighting how considerations may contrast for investors based in the EU vs. US. CGT is a complex and competitive field and raising capital remains challenging for companies at any stage. Different regions mean distinctive markets for fundraising, and it is important to have a current understanding of how institutional investment processes and perspectives may vary.
Session Objectives:
- Is it different to raise capital in the EU vs. the US? How may investment behavior vary?
- What are the key considerations for institutional investors and what makes an opportunity attractive?
- What types of products, technologies and companies investors are most interested in deploying capital towards.
